Inform Genomics Appoints Carl de Moor

Inform Genomics, Inc has announced the appointment of Carl de Moor, PhD, as Chief Technology Officer.

"We are very pleased to have Carl join Inform Genomics as a member of our senior management and executive team. Carl's vast industry and academic expertise in the biostatistics and health outcomes space will significantly aid Inform Genomics as we continue to grow the Company," said Ed Rubenstein, MD, President and CEO of Inform Genomics.

Dr de Moor has more than 25 years of experience in epidemiology, biostatistics, and health outcomes research. His areas of expertise include pharmacoepidemiologic study designs, patient-reported outcome (PRO) assessment methodology and analysis, predictive modeling, longitudinal and time varying modeling, correlated data methods, and multivariate methods.

Prior to joining Inform Genomics, Dr de Moor was Senior Principal Epidemiology and Lead, Epidemiology Center of Excellence, at IMS Health, where he designed and directed retrospective epidemiologic research.

He has served in several executive roles in industry, including Vice President of Epidemiology at MAPI, a late-phase CRO; Executive Director Epidemiology and Health Outcomes at PPD, Inc.; and Vice President of Health Outcomes and Pharmacoeconomics at Supportive Oncology Services, Inc, an oncology CRO.